IL1B and Insulin resistance: The connection between statins, NLRP3/IL-1β, and insulin resistance remains to be characterized in depth, and many mechanistic questions are still unsolved; understanding these aspects might pave the way for new therapeutic strategies, including a combination of statins and IL-1β inhibition.